A detailed history of Verition Fund Management LLC transactions in Galapagos Nv stock. As of the latest transaction made, Verition Fund Management LLC holds 20,270 shares of GLPG stock, worth $634,248. This represents 0.0% of its overall portfolio holdings.

Number of Shares
20,270
Previous 31,313 35.27%
Holding current value
$634,248
Previous $876,000 19.86%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

SELL
$27.87 - $34.64 $307,768 - $382,529
-11,043 Reduced 35.27%
20,270 $702,000
Q2 2025

Aug 14, 2025

BUY
$23.04 - $29.2 $28,523 - $36,149
1,238 Added 4.12%
31,313 $876,000
Q1 2025

May 15, 2025

BUY
$22.69 - $28.79 $281,038 - $356,592
12,386 Added 70.02%
30,075 $755,000
Q4 2024

Feb 14, 2025

BUY
$25.22 - $31.05 $446,116 - $549,243
17,689 New
17,689 $486,000

Others Institutions Holding GLPG

About GALAPAGOS NV


  • Ticker GLPG
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 65,835,500
  • Market Cap $2.06B
  • Description
  • Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...
More about GLPG
Track This Portfolio

Track Verition Fund Management LLC Portfolio

Follow Verition Fund Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Verition Fund Management LLC with notifications on news.